Early May vitamin C trading showed prices firming modestly, sustaining a bullish run that gained momentum through April, with buyers adopting a cautious, range-bound stance as imports from Asian producers influence procurement. Demand patterns remained bifurcated across markets: food applications, bakery, and extrusion, stayed robust as micro- and nano-encapsulation advances bolster formulation inclusion and help preserve potency during processing. Conversely, the supplements and nutraceuticals channel exerted headwinds on synthetic ascorbic acid as a substitution for natural-source acerola, which reduces activity; acerola constitutes a meaningful share of related applications. Downstream buyers remained constructive, supported by an upturn in activity and import dependence that keeps bids responsive to overseas offers. On the supply side, feedstock developments and logistics shaped pricing dynamics. Acetone cost pressures and steady freight conditions maintained a tilt, while potential Chinese plant turnarounds pose upside risk to export availability. The outlook points to firm yet range-bound activity driven by formulation uptake and overseas moves, with substitutions and logistics as moderating factors.
